Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

BACKGROUND: Retention rate, efficacy, and safety of abatacept (ABA) was compared between patients with rheumatoid arthritis receiving ABA as monotherapy to those in combination ABA + conventional synthetic DMARD (csDMARD). METHODS: The patients were obtained from the ORA registry. The retention rate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Truchetet, Marie-Elise, Poursac, Nicolas, Barnetche, Thomas, Shipley, Emilie, Gottenberg, Jacques-Eric, Bannwarth, Bernard, Richez, Christophe, Schaeverbeke, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4815200/
https://ncbi.nlm.nih.gov/pubmed/27029339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0956-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados